1. Agnoli, A., Falaschi, P., Baldassarre, M., Rocco, A., Delroscio, S., D'Urso, R., Ruggieri, S.: Neuroendocrine approach in parkinsonian syndromes. In: Progress in Psychoneuroendocrinology, pp. 315?324. Amsterdam-New York-Oxford: Elsevier/North-Holland Biomedical Press. 1980.
2. Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol.19, 627 to 629 (1967).
3. Balldin, J., Bolle, P., Edén, S., Eriksson, E., Modigh, K.: Effects of electroconvulsive therapy on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats. Psychoneuroendocrinology5, 329?337 (1980 a).
4. Balldin, J., Edén, S., Granérus, A.-K., Modigh, K., Svanborg, A., Wålinder, J., Wallin, L.: Electroconvulsive therapy in Parkinson's syndrome with ?on-off? phenomenon. J. Neural Transm.47, 11?21 (1980 b).
5. Barbeau, A.: The clinical physiology of side effects in long-term L-dopa treatment. In: Advances in Neurology (McDowell, F. H., Barbeau, A., eds.), Vol. 5, pp. 347?365. New York: Raven Press. 1974.